Shinichi Tsujimoto

13PUBLICATIONS
63CO-AUTHORS
Medical infection agents (incl. prions)Haematological tumoursCancer diagnosisInfant and child healthMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 29, 2026
Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.

|Aug 26, 2025
Multi-omics analysis identifies an M-MDSC-like immunosuppressive phenotype in lineage-switched AML with KMT2A rearrangement.

Takashi Mikami, Itaru Kato, Akira Nishimura

|Feb 01, 2025
Establishment of a high-risk pediatric AML-derived cell line YCU-AML2 with genetic and metabolic vulnerabilities.

Junji Ikeda, Norio Shiba, Shota Kato

|Feb 17, 2024
Assessing the efficacy of target adaptive sampling long-read sequencing through hereditary cancer patient genomes.

Wataru Nakamura, Makoto Hirata, Satoyo Oda

|Dec 06, 2023
High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core-binding factor.

Takahiro Aoki, Norio Shiba, Shinichi Tsujimoto

|Jul 09, 2022
A phase III clinical trial evaluating efficacy and safety of minimal residual disease-based risk stratification for children with acute myeloid leukemia, incorporating a randomized study of gemtuzumab ozogamicin in combination with post-induction chemotherapy for non-low-risk patients (JPLSG-AML-20).

Daisuke Tomizawa, Shin-Ichi Tsujimoto, Shiro Tanaka

Pageof 3

Frequent Collaborators

11 joint publications

Daisuke Tomizawa

4 joint publications

Tomoo Osumi

4 joint publications

Kimikazu Matsumoto

4 joint publications

Motohiro Kato